Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is inviting proposals for the funding opportunity titled "Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)." This initiative aims to support research focused on developing effective prevention strategies to reduce prenatal alcohol exposure and enhance interventions for individuals affected by Fetal Alcohol Spectrum Disorders (FASD) throughout their lifespan. The funding will be allocated through an Exploratory/Developmental Phased Award mechanism, with the R61 phase dedicated to pilot studies and hypothesis development, while the R33 phase will expand on successful interventions. Interested applicants can apply for a total funding ceiling of $350,000 for the R61 phase and $500,000 per year for the R33 phase, with proposals due by 5:00 PM local time on January 16, 2024, and subsequent deadlines. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-068.html.
Eligible Applicants
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.